{
    "code": "51059420",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51059420",
    "time": "2021-10-08 08:23:58",
    "許可證字號": "衛部藥製字第059420號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/17",
    "發證日期": "106\/01\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05105942001",
    "中文品名": "欄滋膜衣錠300毫克",
    "英文品名": "&quot;UBIP&quot; Lamivudine Film Coated Tablets 300mg",
    "適應症": "與其他抗反轉錄病毒劑合併使用、治療成人及兒童之人體免疫缺乏病毒(HIV)感染。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000錠塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LAMIVUDINE",
    "限制項目": "01國　產 24監視期滿學名藥 62完成溶離率試驗",
    "申請商名稱": "6233063768  聯亞藥業股份有限公司",
    "申請商地址": "新竹縣湖口鄉光復北路45號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049072004 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818001400",
            "成分名稱": "LAMIVUDINE",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "白色錠劑，菱形，長約1.8公分，正面刻痕UBI 07，反面刻痕300",
        "特殊劑型": "",
        "顏色": "白色菱形錠劑",
        "特殊氣味": "無",
        "刻痕": "有",
        "形狀": "菱形",
        "標記一": "UBI 07",
        "標記二": "300"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "K3840-02_Label_Lamivudine_300mg_20170215-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=005&Type=10"
        },
        {
            "title": "3840U-tablets-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=004&Type=10"
        },
        {
            "title": "3840U-bottle-2-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=003&Type=10"
        },
        {
            "title": "3840U-bottle-1-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=002&Type=10"
        },
        {
            "title": "51059420-106-02-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "L384-01_p.02_Leaflet_Lamivudine_300mg_20170206-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=003&Type=9"
        },
        {
            "title": "L384-01_p.01_Leaflet_Lamivudine_300mg_20170206-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=002&Type=9"
        },
        {
            "title": "仿單_外部上傳_LAMIVUDINE_300MG_20151216-106-02-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=001&Type=9"
        },
        {
            "title": "3840U-carton-2-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=005&Type=8"
        },
        {
            "title": "3840U-carton-1-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=004&Type=8"
        },
        {
            "title": "M3840-02_CTN_LAMIVUDINE_300MG_20170215-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=003&Type=8"
        },
        {
            "title": "外盒_LAMIVUDINE_300MG_20151216-106-02-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=002&Type=8"
        },
        {
            "title": "標籤_LAMIVUDINE_300MG_20150901-106-02-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059420&Seq=001&Type=8"
        }
    ]
}